CRL Price / Book | CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. price/book ratio for the quarter ending 2026-06-27 was 3.66, a 66.51% increase year-over-year.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. price/book ratio for the quarter ending 2026-03-28 was 2.66, a 7.00% increase year-over-year.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. price/book ratio for the quarter ending 2025-12-27 was 3.17, a 15.18% increase year-over-year.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. price/book ratio for the quarter ending 2025-09-27 was 2.15, a 20.68% decline year-over-year.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. price/book ratio for fiscal 2026 was 3.66.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. price/book ratio for fiscal 2025 was 3.17, a 15.18% increase from fiscal 2024.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. price/book ratio for fiscal 2024 was 2.75, a 18.49% decline from fiscal 2023.
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. price/book ratio for fiscal 2023 was 3.37, a 9.53% decline from fiscal 2022.

Available history: 2009-12-26 to 2026-06-27
Data captured: 2026-06-27

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-27	3.66	$10.39B	$2.84B
2026-03-28	2.66	$7.84B	$2.94B
2025-12-27	3.17	$10.03B	$3.16B
2025-09-27	2.15	$7.31B	$3.41B
2025-06-28	2.2	$7.37B	$3.35B
2025-03-29	2.49	$7.96B	$3.19B
2024-12-28	2.75	$9.52B	$3.46B
2024-09-28	2.71	$10.24B	$3.78B
2024-06-29	2.86	$10.64B	$3.72B
2024-03-30	3.82	$13.91B	$3.64B
2023-12-30	3.37	$12.14B	$3.6B
2023-09-30	3.04	$10.05B	$3.31B
2023-07-01	3.31	$10.76B	$3.25B
2023-04-01	3.31	$10.29B	$3.11B
2022-12-31	3.73	$11.1B	$2.98B
2022-09-24	3.63	$9.54B	$2.63B
2022-06-25	4.34	$11.5B	$2.65B
2022-03-26	5.4	$14.09B	$2.61B
2021-12-25	7.35	$18.64B	$2.53B
2021-09-25	9.52	$23.1B	$2.43B
2021-06-26	7.97	$18.49B	$2.32B
2021-03-27	6.57	$14.34B	$2.18B
2020-12-26	5.92	$12.53B	$2.11B
2020-09-26	5.68	$10.77B	$1.9B
2020-06-27	4.8	$8.41B	$1.75B
2020-03-28	3.74	$6.18B	$1.65B
2019-12-28	4.55	$7.43B	$1.63B
2019-09-28	4.22	$6.47B	$1.53B
2019-06-29	4.75	$6.92B	$1.46B
2019-03-30	5.01	$7B	$1.4B
2018-12-29	4.09	$5.39B	$1.32B
2018-09-29	5.16	$6.46B	$1.25B
2018-06-30	4.55	$5.38B	$1.18B
2018-03-31	4.44	$5.06B	$1.14B
2017-12-30	4.96	$5.19B	$1.05B
2017-09-30	5.03	$5.14B	$1.02B
2017-07-01	5	$4.82B	$963.5M
2017-04-01	4.86	$4.26B	$876.43M
2016-12-31	4.31	$3.61B	$836.77M
2016-09-24	4.51	$3.91B	$867.97M
2016-06-25	4.56	$3.79B	$831.35M
2016-03-26	4.45	$3.47B	$779.82M
2015-12-26	5.1	$3.74B	$733.07M
2015-09-26	4.3	$3.03B	$704.36M
2015-06-27	4.84	$3.4B	$701.7M
2015-03-28	5.68	$3.77B	$663.71M
2014-12-27	4.53	$3.04B	$672.2M
2014-09-27	4.15	$2.78B	$670.3M
2014-06-28	3.8	$2.55B	$671.82M
2014-03-29	4.07	$2.83B	$695.46M
2013-12-28	3.96	$2.54B	$640.98M
2013-09-28	3.46	$2.27B	$656.51M
2013-06-29	3.11	$2.01B	$647.95M
2013-03-30	3.4	$2.13B	$628.28M
2012-12-29	2.96	$1.78B	$600.81M
2012-09-29	3.23	$1.93B	$597.71M
2012-06-30	2.85	$1.61B	$562.84M
2012-03-31	3.19	$1.76B	$552.6M
2011-12-31	2.54	$1.34B	$525.58M
2011-09-24	2.82	$1.52B	$539.71M
2011-06-25	3.45	$2.03B	$589.09M
2011-03-26	3.88	$2.19B	$562.92M
2010-12-25	2.93	$2.01B	$687.42M
2010-09-25	2.06	$2.14B	$1.04B
2009-12-26	1.58	$2.17B	$1.38B

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-27	3.66	$10.39B	$2.84B
2025-12-27	3.17	$10.03B	$3.16B
2024-12-28	2.75	$9.52B	$3.46B
2023-12-30	3.37	$12.14B	$3.6B
2022-12-31	3.73	$11.1B	$2.98B
2021-12-25	7.35	$18.64B	$2.53B
2020-12-26	5.92	$12.53B	$2.11B
2019-12-28	4.55	$7.43B	$1.63B
2018-12-29	4.09	$5.39B	$1.32B
2017-12-30	4.96	$5.19B	$1.05B
2016-12-31	4.31	$3.61B	$836.77M
2015-12-26	5.1	$3.74B	$733.07M
2014-12-27	4.53	$3.04B	$672.2M
2013-12-28	3.96	$2.54B	$640.98M
2012-12-29	2.96	$1.78B	$600.81M
2011-12-31	2.54	$1.34B	$525.58M
2010-12-25	2.93	$2.01B	$687.42M
2009-12-26	1.58	$2.17B	$1.38B

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Medpace Holdings, Inc. (MEDP)	United States	$17.316B	30.09
INCYTE CORP (INCY)	United States	$24.855B	13.14
Absci Corp (ABSI)	United States	$1.775B	-14.92
OmniAb, Inc. (OABI)	United States	$0.698B	-8.05
NRC HEALTH (NRC)	United States	$0.450B	42.50
MAXCYTE, INC. (MXCT)	United States	$0.124B	-3.68
bioAffinity Technologies, Inc. (BIAF)	United States	$0.063B
OneMedNet Corp (ONMD)		$0.042B
iSpecimen Inc. (ISPC)	United States	$0.003B
FOXO TECHNOLOGIES INC. (FOXO)	United States	$0.000B	-277.71